91% of pancreatic cancer patients die within 5 years– often because the cancer is too advanced to treat by the time of diagnosis. An early detection test for pancreatic cancer would be the most effective weapon to save lives from this disease.
Pancreatic cancer is one example of the limitations of the current system to address deadly diseases with urgency. Despite decades of medical innovation, millions of Americans with fatal and debilitating conditions have seen no progress. The current path from basic science to applied research to commercial viability is too slow. Research is not getting to patients fast enough.LEARN MORE ABOUT
CodePurple advocates for HARPA – a Health Advanced Research Projects Agency – as the most promising vehicle to develop a pancreatic cancer detection test. HARPA, modeled after the spectacularly successful DARPA unit at the Department of Defense, would leverage federal research assets and private sector tools to build new capabilities for diseases that have not benefitted from the current system.
HARPA would tackle our most urgent medical challenges. An early detection test for pancreatic cancer would be a top priority.LEARN MORE